Literature DB >> 16122695

Corepressor CtBP1 interacts with and specifically inhibits CBP activity.

Vitalyi Senyuk1, Kislay Kumar Sinha, Giuseppina Nucifora.   

Abstract

Transcription repression in eukaryotes is mediated by a wide variety of transcription factors that usually recruit corepressors and form corepressor complexes at the specific promoter sites. One of these corepressors is the C-terminal-binding protein (CtBP) which was first identified as a protein that binds to the C-terminal region of the adenovirus E1A protein. CtBP has a strong role in both development and oncogenesis. Till date, the mechanism of transcription repression by CtBP is unknown. Here, we report that CtBP physically interacts in vivo with HAT enzymes from different families. The vast majority of the HAT enzymes have a potential consensus site for CtBP binding within the bromodomain but we show that additional site(s) exists for CBP. The interaction between CtBP and CBP is functionally important and leads to impairment of histone H3 acetylation by CBP at specific lysine residues (Lys9, Lys14, and Lys18) in a dose-dependent and NADH-dependent manner. Based on these results, we propose that CtBP1 mediates repression by blocking histone acetylation by HAT complexes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122695     DOI: 10.1016/j.abb.2005.06.024

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Role of the C-terminal binding protein PXDLS motif binding cleft in protein interactions and transcriptional repression.

Authors:  Kate G R Quinlan; Alexis Verger; Alister Kwok; Stella H Y Lee; José Perdomo; Marco Nardini; Martino Bolognesi; Merlin Crossley
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

2.  Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.

Authors:  M Kuppuswamy; S Vijayalingam; Ling-Jun Zhao; Yun Zhou; T Subramanian; Jan Ryerse; G Chinnadurai
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

3.  Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3.

Authors:  Beat Amstutz; Michele Gastaldelli; Stefan Kälin; Nicola Imelli; Karin Boucke; Eliane Wandeler; Jason Mercer; Silvio Hemmi; Urs F Greber
Journal:  EMBO J       Date:  2008-03-06       Impact factor: 11.598

Review 4.  Role of the hypothalamus in mediating protective effects of dietary restriction during aging.

Authors:  Penny A Dacks; Cesar L Moreno; Esther S Kim; Bridget K Marcellino; Charles V Mobbs
Journal:  Front Neuroendocrinol       Date:  2012-12-20       Impact factor: 8.606

5.  C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling.

Authors:  Pengyun Wang; Benfeng Yu; Chengyan Wang; Shu Zhou
Journal:  J Cell Commun Signal       Date:  2019-06-19       Impact factor: 5.782

Review 6.  The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.

Authors:  Melanie A Blevins; Mingxia Huang; Rui Zhao
Journal:  Mol Cancer Ther       Date:  2017-06       Impact factor: 6.261

7.  Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1.

Authors:  Fabio Stossi; Zeynep Madak-Erdogan; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

8.  C-terminal of E1A binding protein 1 enhances the migration of gastric epithelial cells and has a clinicopathologic significance in human gastric carcinoma.

Authors:  Can Wang; Min Wang; Bocheng Xing; Zhaocheng Chi; Hongyu Wang; Chunxiao Lie; Han Dong
Journal:  Onco Targets Ther       Date:  2019-07-02       Impact factor: 4.147

Review 9.  The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases.

Authors:  Zhi Chen
Journal:  J Mol Med (Berl)       Date:  2021-07-01       Impact factor: 4.599

10.  SWI/SNF complexes act through CBP-1 histone acetyltransferase to regulate acute functional tolerance to alcohol.

Authors:  Laura D Mathies; Jonathan H Lindsay; Amal P Handal; GinaMari G Blackwell; Andrew G Davies; Jill C Bettinger
Journal:  BMC Genomics       Date:  2020-09-21       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.